Cannabidiol's stability and functional properties were investigated. The phytocannabinoid showed excellent antioxidant, anti-collagenase properties along with antimicrobial properties against Gram-positive bacterial and fungal species which suggest opportunities as an ingredient in topical products.
Cannabidiol (CBD) is a non-psychoactive compound derived from cannabis and has attracted considerable attention due to its potential therapeutic benefits.
A new polymorph of cannabidiol (CBD, form 2), a bioactive phytocannabinoid, was discovered via high-throughput crystallisation. CBD form 2 fits within a series of crystal structures of CBD C-5′ homologues, forming a set of homologous isomorphs.
The derivatization of THC and CBD for improved bioactivity is reviewed, demonstrating the pharmacophoric versatility, and the limitations of chemical modification, of the cannabinoids. Regulatory and scientific challenges are highlighted.
Cannabidiol (CBD) has been reported to have a plethora of therapeutic opportunities in many diseases.